| 1. |
Duchateau L, Pignon JP, Bijnens L, et al. Individual Patient- versus Literature-Based Meta-analysis of Survival Data: Time to Event and Event Rate at a Particular Time Can Make a Difference, an Example Based on Head and Neck Cancer. Control Clin Trials, 2001, 22(5): 538-547.
|
| 2. |
Stewart LA, Parmar MK. Meta-analysis of the literature or of individual patient data: is there a difference? Lancet, 1993, 341(8842): 418-422.
|
| 3. |
Clarke M, Stewart L, Parmar M. Benefits of meta-analysis using individual patient data. in Cochrane Colloquium. 1995. Olso.
|
| 4. |
Neoadjuvant Chemotherapy for Cervical Cancer Meta-Analysis Collaboration (NACCCMA) Collaboration. Neoadjuvant chemotherapy for locally advanced cervix cancer. Cochrane Database Syst Rev, 2004, (2): CD001774.
|
| 5. |
Gray R, Clarke M, Collins R, et al. The EBCTCG Overview of Adjuvant Therapy of Breast Cancer. Annals of the New York Academy of Sciences, 698(1): 339-348.
|
| 6. |
Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet, 2005, 366(9503): 2087-2106.
|
| 7. |
Chia S, Bryce C, Gelmon K. The 2000 EBCTCG overview: a widening gap. Lancet, 2005, 365(9472): 1665-1666.
|
| 8. |
Stewart LA, Tierney JF. To IPD or not to IPD? Advantages and disadvantages of systematic reviews using individual patient data. Eval Health Prof, 2002, 25(1): 76-97.
|
| 9. |
Hollis S, Campbell F. What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ, 1999, 319(7211): 670-674.
|
| 10. |
Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med, 1998, 17(24): 2815-2834.
|
| 11. |
Smith CT, Williamson PR, Marson AG. An overview of methods and empirical comparison of aggregate data and individual patient data results for investigating heterogeneity in meta-analysis of time-to-event outcomes. J Eval Clin Pract, 2005, 11(5): 468-478.
|
| 12. |
Teramukai S, Matsuyama Y, Mizuno S, et al. Individual patient-level and study-level meta-analysis for investigating modifiers of treatment effect. Jpn J Clin Oncol, 2004, 34(12): 717-721.
|
| 13. |
Rovers MM, Glasziou P, Appelman CL, et al. Predictors of pain and/or fever at 3 to 7 days for children with acute otitis media not treated initially with antibiotics: a metaanalysis of individual patient data. Pediatrics, 2007, 119(3): 579-585.
|
| 14. |
[No authors listed]. Echocardiographic predictors of stroke in patients with atrial fibrillation: a prospective study of 1066 patients from 3 clinical trials. Arch Intern Med, 1998, 158(12): 1316-1320.
|
| 15. |
Barbui C, Cipriani A, Geddes JR. Antidepressants and suicide symptoms: compelling new insights from the FDA’s analysis of individual patient level data. Evid Based Ment Health, 2008, 11(2): 34-35.
|
1/5
微信公众号